CDx Diagnostics
PrivateLast Round
VC Round
Dec 1, 2019
Total Funding Raised
$60M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CDx Diagnostics operates in Healthcare & Life Sciences and is based in Suffern, New York. Its latest recorded funding round was a VC Round in December 2019.
CDx Diagnostics is a healthcare company that provides specialized anatomic pathology laboratory services and AI-powered diagnostic technology for the early detection of precancerous and cancerous tissue.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CDx Diagnostics Comparables
Compare CDx Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucid Diagnostics Inc. | 78% | |
| Castle Biosciences, Inc. | 77% | |
| ProPhase Labs Inc | 71% |
For institutional investors. Book with your work email.
CDx Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2019 | ||||
| Private Equity | Jul 11, 2017 | ||||
| Debt | Jul 11, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CDx Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Galen Partners | Private Equity |
| White Oak Healthcare Finance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 78% MoM.
- Apr 8, 2026
Monthly visitors increased 47% MoM.
For institutional investors. Book with your work email.
CDx Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CDx Diagnostics's valuation, stock price, and market status.
Is CDx Diagnostics a public or private company?
CDx Diagnostics is a private company.
What is the current stock price of CDx Diagnostics?
CDx Diagnostics is a private company, so its shares have no public market price. Caplight tracks CDx Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CDx Diagnostics worth (valuation)?
Valuation information for CDx Diagnostics is not publicly available.
Can I buy CDx Diagnostics stock?
CDx Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CDx Diagnostics's last funding round?
CDx Diagnostics's most recent funding round was VC Round on December 1, 2019.
Who are the main investors in CDx Diagnostics?
Key investors in CDx Diagnostics include Galen Partners, White Oak Healthcare Finance.
Will CDx Diagnostics IPO soon?
No public IPO plans have been announced for CDx Diagnostics.
How can I track CDx Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in CDx Diagnostics's shares on secondary markets.